BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garate M, Wani AA, Li G. The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells. Free Radic Biol Med. 2010;48:1601-1609. [PMID: 20226854 DOI: 10.1016/j.freeradbiomed.2010.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Maldonado V, Melendez-Zajgla J. Role of Bcl-3 in solid tumors. Mol Cancer 2011;10:152. [PMID: 22195643 DOI: 10.1186/1476-4598-10-152] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
2 Osman NATAG, Abd El-Maqsoud NMR, El Gelany SAA. Correlation of NQO1 and Nrf2 in Female Genital Tract Cancer and Their Precancerous Lesions (Cervix, Endometrium and Ovary). World J Oncol 2015;6:364-74. [PMID: 28983331 DOI: 10.14740/wjon931w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Medina-Carmona E, Palomino-Morales RJ, Fuchs JE, Padín-Gonzalez E, Mesa-Torres N, Salido E, Timson DJ, Pey AL. Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands. Sci Rep 2016;6:20331. [PMID: 26838129 DOI: 10.1038/srep20331] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
4 Sztiller-Sikorska M, Koprowska K, Majchrzak K, Hartman M, Czyz M. Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells. PLoS One 2014;9:e90783. [PMID: 24595456 DOI: 10.1371/journal.pone.0090783] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
5 Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] [Reference Citation Analysis]
6 Thapa D, Meng P, Bedolla RG, Reddick RL, Kumar AP, Ghosh R. NQO1 suppresses NF-κB-p300 interaction to regulate inflammatory mediators associated with prostate tumorigenesis. Cancer Res 2014;74:5644-55. [PMID: 25125658 DOI: 10.1158/0008-5472.CAN-14-0562] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
7 Liu K, Jin B, Wu C, Yang J, Zhan X, Wang L, Shen X, Chen J, Chen H, Mao Z. NQO1 Stabilizes p53 in Response to Oncogene-Induced Senescence. Int J Biol Sci 2015;11:762-71. [PMID: 26078718 DOI: 10.7150/ijbs.11978] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
8 Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S, Chen L. Clinical implications of high NQO1 expression in breast cancers. J Exp Clin Cancer Res. 2014;33:14. [PMID: 24499631 DOI: 10.1186/1756-9966-33-14] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 10.9] [Reference Citation Analysis]
9 Zhang K, Chen D, Ma K, Wu X, Hao H, Jiang S. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer. J Med Chem 2018;61:6983-7003. [DOI: 10.1021/acs.jmedchem.8b00124] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 13.5] [Reference Citation Analysis]
10 Dai F, Du YT, Zheng YL, Zhou B. A promising redox cycle-based strategy for designing a catechol-type diphenylbutadiene as a potent prooxidative anti-melanoma agent. Free Radic Biol Med 2019;130:489-98. [PMID: 30458279 DOI: 10.1016/j.freeradbiomed.2018.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dias GG, King A, de Moliner F, Vendrell M, da Silva Júnior EN. Quinone-based fluorophores for imaging biological processes. Chem Soc Rev 2018;47:12-27. [PMID: 29099127 DOI: 10.1039/c7cs00553a] [Cited by in Crossref: 57] [Cited by in F6Publishing: 11] [Article Influence: 14.3] [Reference Citation Analysis]
12 Clavería-Gimeno R, Velazquez-Campoy A, Pey AL. Thermodynamics of cooperative binding of FAD to human NQO1: Implications to understanding cofactor-dependent function and stability of the flavoproteome. Arch Biochem Biophys 2017;636:17-27. [PMID: 29100982 DOI: 10.1016/j.abb.2017.10.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
13 Soengas MS. Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: implications for melanoma progression and drug resistance. Pigment Cell Melanoma Res 2012;25:721-31. [DOI: 10.1111/pcmr.12021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
14 Pidugu LS, Mbimba JC, Ahmad M, Pozharski E, Sausville EA, Emadi A, Toth EA. A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone. BMC Struct Biol 2016;16:1. [PMID: 26822308 DOI: 10.1186/s12900-016-0052-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
15 Butsri S, Kukongviriyapan V, Senggunprai L, Kongpetch S, Zeekpudsa P, Prawan A. Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells. Oncol Lett 2017;13:4540-8. [PMID: 28599455 DOI: 10.3892/ol.2017.5951] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
16 Dimri M, Humphries A, Laknaur A, Elattar S, Lee TJ, Sharma A, Kolhe R, Satyanarayana A. NAD(P)H Quinone Dehydrogenase 1 Ablation Inhibits Activation of the Phosphoinositide 3-Kinase/Akt Serine/Threonine Kinase and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathways and Blocks Metabolic Adaptation in Hepatocellular Carcinoma. Hepatology 2020;71:549-68. [PMID: 31215069 DOI: 10.1002/hep.30818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
17 Zhu Y, Han J, Zhang Q, Zhao Z, Wang J, Xu X, Hao H, Zhang J. A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells. RSC Adv 2019;9:26729-33. [DOI: 10.1039/c9ra05650e] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Gañán-Gómez I, Wei Y, Yang H, Boyano-Adánez MC, García-Manero G. Oncogenic functions of the transcription factor Nrf2. Free Radic Biol Med 2013;65:750-64. [PMID: 23820265 DOI: 10.1016/j.freeradbiomed.2013.06.041] [Cited by in Crossref: 133] [Cited by in F6Publishing: 129] [Article Influence: 14.8] [Reference Citation Analysis]
19 Ma Y, Kong J, Yan G, Ren X, Jin D, Jin T, Lin L, Lin Z. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:414. [PMID: 24912939 DOI: 10.1186/1471-2407-14-414] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
20 Cui X, Li L, Yan G, Meng K, Lin Z, Nan Y, Jin G, Li C. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. BMC Cancer 2015;15:244. [PMID: 25885439 DOI: 10.1186/s12885-015-1271-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
21 Li Z, Zhang Y, Jin T, Men J, Lin Z, Qi P, Piao Y, Yan G. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. BMC Cancer. 2015;15:207. [PMID: 25880877 DOI: 10.1186/s12885-015-1227-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
22 Jamshidi M, Bartkova J, Greco D, Tommiska J, Fagerholm R, Aittomäki K, Mattson J, Villman K, Vrtel R, Lukas J, Heikkilä P, Blomqvist C, Bartek J, Nevanlinna H. NQO1 expression correlates inversely with NFκB activation in human breast cancer. Breast Cancer Res Treat 2012;132:955-68. [DOI: 10.1007/s10549-011-1629-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
23 Røe OD, Szulkin A, Anderssen E, Flatberg A, Sandeck H, Amundsen T, Erlandsen SE, Dobra K, Sundstrøm SH. Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma. PLoS One 2012;7:e40521. [PMID: 22905093 DOI: 10.1371/journal.pone.0040521] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
24 Ji M, Jin A, Sun J, Cui X, Yang Y, Chen L, Lin Z. Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. Oncol Lett. 2017;13:2996-3002. [PMID: 28521407 DOI: 10.3892/ol.2017.5821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
25 Lin L, Qin Y, Jin T, Liu S, Zhang S, Shen X, Lin Z. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma. Exp Mol Pathol. 2014;96:200-205. [PMID: 24384455 DOI: 10.1016/j.yexmp.2013.12.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
26 Ong AJ, Saeidi S, Chi NHK, Kim SJ, Kim DH, Kim SH, Park SA, Cha YN, Na HK, Surh YJ. The positive feedback loop between Nrf2 and phosphogluconate dehydrogenase stimulates proliferation and clonogenicity of human hepatoma cells. Free Radic Res 2020;54:906-17. [PMID: 32336239 DOI: 10.1080/10715762.2020.1761547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Muñoz IG, Morel B, Medina‐carmona E, Pey AL. A mechanism for cancer‐associated inactivation of NQO1 due to P187S and its reactivation by the consensus mutation H80R. FEBS Lett 2017;591:2826-35. [DOI: 10.1002/1873-3468.12772] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
28 Lamberti MJ, Morales Vasconsuelo AB, Chiaramello M, Ferreira VF, Macedo Oliveira M, Baptista Ferreira S, Rivarola VA, Rumie Vittar NB. NQO1 induction mediated by photodynamic therapy synergizes with β-Lapachone-halogenated derivative against melanoma. Biomed Pharmacother 2018;108:1553-64. [PMID: 30372857 DOI: 10.1016/j.biopha.2018.09.159] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
29 Ross D, Zhou H, Siegel D. Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function. Chem Biol Interact 2011;192:145-9. [PMID: 20970411 DOI: 10.1016/j.cbi.2010.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
30 Mori F, Tanigawa K, Endo K, Minamiguchi K, Abe M, Yamada S, Miyoshi K. VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia: VAT-1 Is a Pathogenic Factor in BPH. Prostate 2011;71:1579-86. [DOI: 10.1002/pros.21374] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]